Company intelligence / Profile preview

TerraBiome

Tel Aviv–Yafo, Israelfinder.startupnationcentral.org ↗

Ownership: Private
Development stage: Preclinical

Overview

TerraBiome has developed a proprietary feed additive derived from microalgae that reduces methane emissions by up to 75% in cows while also increasing feed digestibility. The product is positioned as a natural nutritional supplement for livestock, with demonstrated efficacy in reducing the environmental impact of cattle farming.

Therapeutic areas: OtherGastroenterology
Modalities: Feed additiveMicrobial therapy (derived from microalgae)
Industry: Veterinary

Beyond the preview

Go deeper on TerraBiome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TerraBiome.

Explore the full profile